This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The latest Akero data build on six-month results reported in 2022. Akero Therapeutics’ preliminary Phase 2b data show that treatment with its MASH drug, efruxifermin, continued to distance itself from a placebo measured at nearly two years of treatment.
In November of 2022, InCrowd surveyed 500 US physicians to track burnout. In 2022, reports showed that physician burnout had risen to frightening levels. Down from 45% in 2021, only 30% of respondents in 2022 find their profession extremely rewarding. The] health system is hard to navigate and [has] too many admin hurdles.”
When the federal government enacted the No Surprises Act to lessen payment disputes between a patient or a health insurance plan and a provider, the government projected 22,000 disputes in 2022. However, between just April and September there were more than 90,000 disputes filed. .
This is your chance to create unprecedented brand awareness, bring in the best leads sales has ever seen, and play an instrumental role in generating new and existing business revenue. Define and agree on “qualified leads”. In this eBook, you’ll discover what it takes to develop and drive a successful marketing-led growth strategy.
Gilead Sciences is increasing its stake in partner Arcellx and expanding the cell therapy alliance the companies started in 2022. The deal expands the lead partnered program to more cancers and gives Gilead a chance at another Arcellx cell therapy candidate made with different technology.
Although none of these resources give a sales-specific hiring forecast, there is enough information between them to accurately predict sales hiring for 2022. Before we present our 2022 hiring sales forecast, it’s interesting to compare Dec 2021 unemployment stats with February 2020 pre-Covid numbers. 2022 Sales Forecast Trends.
are behind on their 2022 revenue goals, and healthcare executives are worried about increasing costs, shrinking margins and the impending recession, according to a new report. Nearly half of health systems and physician groups in the U.S.
Elements leading to a rational design of cyclodextrin-based formulations. The post European Pharmaceutical Review Issue 5 2022 appeared first on European Pharmaceutical Review. Lindsey Silva, Carmen Marín Delgado de Robles, Viviane Grunert da Fonseca and Evelyn Der, Roche Group. An Annex 1 and Pharma 4.0 perspective on water quality.
Elements leading to a rational design of cyclodextrin-based formulations. The post Drug Formulation In-Depth Focus 2022 appeared first on European Pharmaceutical Review. Colin Freund, Chief Executive Officer of Modra Pharmaceuticals, reveals the benefits of this emerging generation of anticancer treatment.
— Circular Digital Health (DiCE project) (@circular_health) October 13, 2022. The post Janssen leads effort to cut waste in digital health devices appeared first on. Great to have you on board @ForumWeee , we look forward to the next four years of collaboration! Photo by Possessed Photography on Unsplash.
Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022. Comirnaty is the leading prophylactic vaccine for Covid-19 and is expected to generate an additional $2.8bn in sales in 2022 compared to GlobalData’s H1 2022 forecast.
Acquisition highlights companies shared commitment to clients, workplace culture, and attracting the industrys best people TORONTO, ON/SARATOGA SPRINGS, NY January 7, 2025 Klick Health today announced it has acquired Peregrine Market Access, a leading market access strategy and value communications specialist in life sciences.
The exceptional individuals designated Highly Cited Researchers 2022 have published multiple highly cited papers, ranking in the top 1% by citations for field and year over the last decade. Celebrating Highly Cited Researchers 2022. Of all the world’s researchers, they are one in 1,000. Research fuels the race for knowledge.
Hear from patients, leading provider and payer executives, investors, and healthcare startups about how to improve the patient experience at the event, which kicks off the first day of the HLTH conference. ENGAGE at HLTH is scheduled for November 13 at the Venetian Expo in Las Vegas.
As of September 2022, 64 of the Citation Laureates named by the Institute for Scientific Information (ISI) at Clarivate went on to receive a Nobel Prize, more than half within three years of being named on our lists. The ongoing impact of our 2022 Citation Laureates. 01%) have been cited 2,000 or more times.
When global trademark filing activity fell in 2022 , questions rose around what this signified. Applications from Mainland China were up by 9% compared with 2022, while Polish applicants filed 19% more EUTM applications than in 2022. Mainland China – 21,701 (up by 9% compared to 2022) 2.
To coincide with the 17th G20 Heads of State and Government Summit taking place in Bali, Clarivate has released its Annual G20 Scorecard – Research Performance 2022. . While GDP has increased by 60% between 2012 and 2020, GERD has doubled in the same period, leading to an increase by a quarter in GERD by GDP.
2022 is probably the biggest year in EU pharmaceutical law that I have seen in 30 years. 2022 is undeniably a critical year for change in the pharmaceutical industry: for the first time in several decades, the European Union (EU)’s pharmaceutical legislation is up for review. ORPHAN DRUG REPORT 2022 [Internet]. Future outlook.
With more than a decade of experience leading and scaling managed care organisations, Grabski is a seasoned business leader and finance executive. In 2022, she won the CFO of the Year Award in the small business category from the San Diego Business Journal for her leadership in building and managing successful financial teams.
The Reuters Pharma event 2022 began as a bustling industry affair yesterday, based out of the Nice Acropolis convention centre on France’s balmy south coast. NB: Part 2 of ’Reuters Pharma 2022 – a day one overview’ will follow shortly…. The post Reuters Pharma 2022 – a day one overview – part 1 appeared first on.
Yet, high drug prices lead to soaring out-of-pocket costs , dangerous drug rationing , and a depletion of limited financial resources —especially for those with fixed incomes. Reforms to let Medicare negotiate prices, cap out-of-pocket costs for prescription drugs, and limit insulin cost-sharing would make lifesaving drugs more affordable.
It is a minimally invasive treatment that has shown tremendous promise in addressing vascular calcification, which increases the risk of heart attacks, strokes, or blood clots, and can lead to limb amputations. It also showed the value of performing one type of procedure at a very high level.
Over-the-Counter (OTC) and Prescription (Rx) brands have invested over $3 billion in linear TV advertising during the first half of 2022, with no signs of letting up. OTC Creative Insights: Nervive , Relaxium Spots Lead in Searches Generated. million online branded searches for the product in 2022. Brand / Creative. Impressions.
Following Nucleus RadioPharma’s 2022 debut, the GE HealthCare- and Mayo Clinic-backed radiopharmaceuticals CDMO is ready to put its production thesis to the test. The production deal will support ARTBIO’s planned phase 1 and 2 clinical trials of its lead program in prostate cancer, AB001.
In response to the urgent need for support, the federally funded National Maternal Mental Health Hotline was launched in 2022, In its first year, the hotline for new and expectant parents received more than 12,000 calls and texts, underlining the depth of the crisis affecting millions of Americans.
Data from brief medication questionnaires can lead to overestimated adherence, given the info is self-reported, but can also result in valuable insights regarding attitude, barriers, influence, and other behavioral attributes.
The report reads like this: “Left anterior chest wall dual-lead pacer stable from prior examination. A device with two leads (dual-lead pacer) is stable in the left front part of your chest, as seen in the previous examination. Lungs hyperinflated to clear. No pneumothorax or pleural eltusion. Pulmonary vasculature normal.
It is worth noting that in the entire human history until 2022, science had discovered a total of about 190,000 different proteins. As mentioned above, in 2022 DeepMinds AlphaFold 2 discovered over 200 million proteins, which were made freely available to researchers.
Julie Kim – Takeda’s future CEO Julie Kim has held the role of president of the US Business Unit and US country head since 2022 , taking over from Ramona Sequeira. I am excited to guide Takeda through the next phase, stated Kim. She has a part of the Takeda Executive Team since 2019.
In 2022, the FDA awarded VX-548 breakthrough therapy and fast-track designations for post-operative pain, and the drug is forecast to reach sales of $416m by 2029. Currently, there are 546 painkillers in active development, with 458 targeting opioid-receptor alternatives, according to GlobalData’s Drugs Database.
There were 175 ongoing trials in 2023, compared to 178 in 2022. According to the CGT Catapult database, the UK has also stayed an attractive location for commercial trials, accounting for 81 percent of these trials in 2023 and 80 percent in 2022. This is a notable increase from 168 in 2021, CGT Catapult highlighted.
Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson. There have been several Phase III trials for Mounjaro, with SURMOUNT-1 demonstrating a weight loss of up to 22.5%
” According to BeiGene, since joining BeiGene in 2022 as the Global Head of Operational Excellence, De la Rocha has “championed impactful changes in clinical development, driving compliance, productivity, and efficiency.” Pilar de la Rocha’s career journey to date Pilar de la Rocha as Head of Europe, Global Clinical Operations, Beigene.
This milestone follows the agreement in principle between Moderna and the UK Government, announced in June 2022. Steve Barclay, Health and Social Care Secretary added: “By boosting our onshore vaccine manufacturing capability, we are a step closer to becoming the leading global hub for life sciences. Moderna, Inc.
“Despite advances, there remains a high unmet need for those with heavily pretreated multiple myeloma as only 30 percent of triple-class exposed patients respond to currently available treatment options,” commented (Res) Dr Edmond Chan, Senior Director EMEA Therapeutic Area Lead Haematology, Janssen-Cilag Limited.
Maja Pedersen has been appointed as Chief Quality Officer (CQO), to lead FUJIFILM Diosynth Biotechnologies’ global quality team. She explained: “I am thrilled to be joining FUJIFILM Diosynth Biotechnologies again and becoming an integral part of leading our teams to develop and embed a transformational quality culture.” “We
Although core to the new EU GMP Annex 1 1 – mentioned more than 50 times in the 2022 version of the document – contamination control strategies are not new. Opening the session, moderator Tim Sandle highlighted six fundamental aspects of contamination control. Early adopters started putting these strategies together around 20 years ago.
Innovative therapies for rare diseases The acquisition will help to drive the growth of CTI’s lead product, kinase inhibitor VONJO ® (pacritinib) “in treating myeloproliferative disease,” stated Dr Adam Craig, President, Chief Executive Officer and Interim Chief Medical Officer of CTI BioPharma.
Galen Growth , a leading digital health, data-driven market intelligence company, and FINN Partners , a global integrated marketing services agency, announced a joint effort to mine data and produce the first “Global State of Digital Health Report.” Additional quarterly reports are anticipated throughout the coming year.
Also, if you’re reading this episode, whether you’re trying to break in, already or a medical sales professional, or you’re leading the way, you’re going to learn something that you probably haven’t heard before. I then got a chance to lead at the director level. — Sam, how are you doing?
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content